Therapeutic application of regeneration-associated cells: a novel
By A Mystery Man Writer
Description
Chronic diseases with comorbidities or associated risk factors may impair the function of regenerative cells and the regenerative microenvironment. Following this consideration, the vasculogenic conditioning culture (VCC) method was developed to boost the regenerative microenvironment to achieve regeneration-associated cells (RACs), which contain vasculogenic endothelial progenitor cells (EPCs) and anti-inflammatory/anti-immunity cells. Preclinical and clinical studies demonstrate that RAC transplantation is a safe and convenient cell population for promoting ischemic tissue recovery based on its strong vasculogenicity and functionality. The outputs of the scientific reports reviewed in the present study shed light on the fact that RAC transplantation is efficient in curing various diseases. Here, we compactly highlight the universal features of RACs and the latest progress in their translation toward clinics.
Interleukin-10 Deficiency Impairs Reparative Properties of Bone
Post-QQc adoptive diabetic progenitor cell therapy accelerates
Abbreviations APB: Adult Peripheral Blood; B reg: Regulatory B
Regeneration-associated cells application. Figure created with
Stromal cells and stem cells in clinical bone regeneration
Characterization of extracellular vesicles. (A–C) Nano tracking
PDF) Therapeutic application of regeneration-associated cells: a
Post-QQc diabetic progenitor cell therapy enhances wound
Therapeutic application of regeneration-associated cells: a novel
from
per adult (price varies by group size)